Exact Mass: 703.2476076

Exact Mass Matches: 703.2476076

Found 20 metabolites which its exact mass value is equals to given mass value 703.2476076, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Tetrahydropteroyltri-L-glutamic acid

(2S)-2-[(4S)-4-[(4S)-4-{[4-({[(6S)-2-amino-4-oxo-5,6,7,8-tetrahydro-1H-pteridin-6-yl]methyl}amino)phenyl]formamido}-4-carboxybutanamido]-4-carboxybutanamido]pentanedioic acid

C29H37N9O12 (703.2561562000001)

Tetrahydropteroyltri-L-glutamic acid (CAS: 4227-85-4), also known as (6S)-H4pteglu3, belongs to the class of organic compounds known as tetrahydrofolic acids and derivatives. These are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit (or a derivative thereof). Tetrahydropteroyltri-L-glutamic acid is a strong basic compound (based on its pKa). In humans, this compound is produced by the bacteria in the gut and may be found in feces or urine. Tetrahydropteroyltri-L-glutamica cid exists in all living species, ranging from bacteria to humans. Tetrahydropteroyltri-L-glutamic acid is an intermediate in the synthesis of methionine by bacteria. It is a substrate for the enzyme 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase which catalyzes the reaction 5-methyltetrahydropteroyltri-L-glutamic acid + L-homocysteine = tetrahydropteroyltri-L-glutamic acid + L-methionine. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

Tetrahydrofolyl-[Glu](n)

2-(4-{4-[(4-{[(2-amino-4-oxo-5,6,7,8-tetrahydro-1H-pteridin-6-yl)methyl]amino}phenyl)formamido]-4-carboxybutanamido}-4-carboxybutanamido)pentanedioic acid

C29H37N9O12 (703.2561562000001)

Tetrahydrofolyl-[Glu](n) is involved in the folate biosynthesis pathway. Tetrahydrofolyl-[Glu](n) can be reversibly converted into Tetrahydrofolyl-[Glu](2) by folylpolyglutamate synthase [EC:6.3.2.17]. Tetrahydrofolyl-[Glu](n) can be irreversibly converted into tetrahydrofolate by gamma-glutamyl hydrolase [EC:3.4.19.9]. Sample structure image shows the case when n=3. Tetrahydrofolyl-[Glu](n) is involved in the folate biosynthesis pathway. Tetrahydrofolyl-[Glu](n) can be reversibly converted into Tetrahydrofolyl-[Glu](2) by folylpolyglutamate synthase [EC:6.3.2.17]. Tetrahydrofolyl-[Glu](n) can be irreversibly converted into tetrahydrofolate by gamma-glutamyl hydrolase [EC:3.4.19.9].

Antibiotic CC 1065

Benzo(1,2-b:4,3-b)dipyrrole-3(2H)-carboxamide, 7-((1,6-dihydro-4-hydroxy-5-methoxy-7-((4,5,8,8a-tetrahydro-7-methyl-4-oxocyclopropa(c)pyrrolo(3,2-e)indol-2(1H)-yl)carbonyl)benzo(1,2-b:4,3-b)dipyrrol-3(2H)-yl)carbonyl)-1,6-dihydro-4-hydroxy-5-methox

C37H33N7O8 (703.2390498000001)

Brecanavir

[(1R,5S,6R)-2,8-dioxabicyclo[3.3.0]oct-6-yl] N-[(2S,3R)-4-(benzo[1,3]dioxol-5-ylsulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate

C33H41N3O10S2 (703.2233246000001)

Enacyloxin IVa

C33H47Cl2NO11 (703.2526012)

DTXSID40990138

C37H33N7O8 (703.2390498000001)

Tetrahydrofolyl-[Glu](n)

Tetrahydropteroyltri-L-glutamate

C29H37N9O12 (703.2561562000001)

C34H41NO15

C34H41NO15 (703.2476076)

2,2-{(1S,2S)-1,2-Cyclohexanediylbis[nitrilo(E)methylylidene]}bis [4,6-bis(2-methyl-2-propanyl)phenol] - trichlorochromium (1:1)

C36H54Cl3CrN2O2 (703.2655754)

5?ˉ-O-(4,4?ˉ-DIMETHOXYTRITYL)-N2-PHENOXYACETYL-2?ˉ-DEOXYGUANOSINE

C39H37N5O8 (703.2642002)

2-{Ethyl[3-({4-[(3-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyra zol-5-yl)amino]-7-quinazolinyl}oxy)propyl]amino}ethyl dihydrogen phosphate (2E)-2-butenedioate (1:1)

C30H35FN7O10P (703.2166952)

(6Z)-2,4-ditert-butyl-6-[[[(1R,2R)-2-[[(E)-(3,5-ditert-butyl-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]cyclohexyl]amino]methylidene]cyclohexa-2,4-dien-1-one,trichlorochromium

C36H54Cl3CrN2O2 (703.2655754)

tert-butyloxycarbonyl-4-(tri-n-butylstannyl)-phenylalanine tetrafluorophenyl ester

C32H45F4NO4Sn (703.2306527999999)

Brecanavir

C33H41N3O10S2 (703.2233246000001)

C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

Rif5 intermediate 3

C35H45NO14 (703.283991)

Antibiotic CC 1065

C37H33N7O8 (703.2390498000001)

D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D000080890 - Duocarmycins D009676 - Noxae > D000477 - Alkylating Agents

N-phenylcarbamic acid [(2R,3R,4S,5S,6S)-2-(hydroxymethyl)-6-methoxy-4,5-bis[oxo-(2-phenylanilino)methoxy]-3-oxanyl] ester

C40H37N3O9 (703.2529672000001)

Tetrahydropteroyltri-L-glutamate

C29H37N9O12 (703.2561562000001)

Tetrahydropteroyltri-L-glutamic acid

C29H37N9O12 (703.2561562000001)

4-hydroxy-7-(4-hydroxy-5-methoxy-7-{3-methyl-7-oxo-5,10-diazatetracyclo[7.4.0.0¹,¹².0²,⁶]trideca-2(6),3,8-triene-10-carbonyl}-1h,2h,6h-pyrrolo[3,2-e]indole-3-carbonyl)-5-methoxy-1h,2h,6h-pyrrolo[3,2-e]indole-3-carboximidic acid

4-hydroxy-7-(4-hydroxy-5-methoxy-7-{3-methyl-7-oxo-5,10-diazatetracyclo[7.4.0.0¹,¹².0²,⁶]trideca-2(6),3,8-triene-10-carbonyl}-1h,2h,6h-pyrrolo[3,2-e]indole-3-carbonyl)-5-methoxy-1h,2h,6h-pyrrolo[3,2-e]indole-3-carboximidic acid

C37H33N7O8 (703.2390498000001)